AMGEN BEGAN U.S. CLINICALS ON ERYTHROPOIETIN IN DECEMBER: FIRM INTENDS TO CARVE ANEMIA MARKET UP THREE WAYS; CLINICALS BRING CASH FROM J&J

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".